title: Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction.
abstract: Antimuscarinic agents are the main drugs used to treat patients with the overactive bladder (OAB) syndrome, defined as urgency, with or without urgency incontinence, usually with increased daytime frequency and nocturia. Since the treatment is not curative and since OAB is a chronic disease, treatment may be life-long. Antimuscarinics are generally considered to be ‘safe’ drugs, but among the more serious concerns related to their use is the risk of cardiac adverse effects, particularly increases in heart rate (HR) and QT prolongation and induction of polymorphic ventricular tachycardia (torsade de pointes). An elevated resting HR has been linked to overall increased morbidity and mortality, particularly in patients with cardiovascular diseases. QT prolongation and its consequences are not related to blockade of muscarinic receptors, but rather linked to inhibition of the hERG potassium channel in the heart. However, experience with terodiline, an antimuscarinic drug causing torsade de pointes in patients, has placed the whole drug class under scrutiny. The potential of the different antimuscarinic agents to increase HR and/or prolong the QT time has not been extensively explored for all agents in clinical use. Differences between drugs cannot be excluded, but risk assessments based on available evidence are not possible.
authors: Wake Forest Institute for Regenerative Medicine,Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157, USA. karl-erik.andersson@med.lu.se
authors: Karl-Erik
authors: KE
authors: Andersson
authors: Lysanne
authors: L
authors: Campeau
authors: Brian
authors: B
authors: Olshansky
references: J Auton Pharmacol. 2001 Apr;21(2):71-8
references: 11679015
references: N Engl J Med. 2005 May 12;352(19):1951-8
references: 15888695
references: Circulation. 1986 Nov;74(5):955-63
references: 3769179
references: Eur Urol. 2000 Jun;37(6):702-8
references: 10828671
references: J Cardiovasc Pharmacol Ther. 2008 Dec;13(4):241-51
references: 18832343
references: Ann Pharmacother. 2009 Dec;43(12):1992-2000
references: 19920160
references: Lancet. 2008 Sep 6;372(9641):817-21
references: 18757091
references: Nature. 2006 Mar 23;440(7083):463-9
references: 16554806
references: Eur Urol. 2008 Sep;54(3):543-62
references: 18599186
references: Am J Physiol Regul Integr Comp Physiol. 2002 May;282(5):R1443-9
references: 11959688
references: J Pharmacol Exp Ther. 2000 Mar;292(3):877-85
references: 10688600
references: Auton Autacoid Pharmacol. 2007 Jan;27(1):1-11
references: 17199870
references: Br J Anaesth. 2003 Mar;90(3):391-4
references: 12594158
references: Pharmacol Rev. 1999 Dec;51(4):651-90
references: 10581327
references: Naunyn Schmiedebergs Arch Pharmacol. 2003 Oct;368(4):316-9
references: 14520506
references: Am J Epidemiol. 1999 May 1;149(9):853-62
references: 10221322
references: Clin Pharmacokinet. 2003;42(14):1243-85
references: 14606931
references: J Hypertens. 2007 Jan;25(1):163-8
references: 17143188
references: World J Urol. 2010 Oct;28(5):651-6
references: 20140437
references: BMJ. 2009 Feb 03;338:b219
references: 19193613
references: Br J Clin Pharmacol. 2010 Jul;70(1):16-23
references: 20642543
references: Br J Pharmacol. 2003 Jan;138(1):156-60
references: 12522085
references: Circulation. 2005 Sep 27;112(13):1959-64
references: 16172270
references: Life Sci. 1997;60(13-14):1053-60
references: 9121347
references: J Urol. 2007 Dec;178(6):2488-94
references: 17937959
references: BJU Int. 2010 Jul;106(2):268-74
references: 19922546
references: Urology. 2006 Feb;67(2):275-80
references: 16461077
references: Heart Fail Rev. 2011 Mar;16(2):109-27
references: 20577901
references: Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1253-8
references: 15130910
references: J Am Coll Cardiol. 2000 Aug;36(2):608-17
references: 10933378
references: BJU Int. 2005 Nov;96(7):1055-62
references: 16225528
references: Eur Urol. 2007 Oct;52(4):1204-12
references: 17651893
references: Expert Opin Pharmacother. 2008 Jul;9(10):1787-96
references: 18570610
references: Life Sci. 2000;66(7):607-15
references: 10794516
references: Br J Pharmacol. 2004 Jun;142(3):395-408
references: 15148264
references: Int J Urol. 2006 Jun;13(6):692-8
references: 16834644
references: Ther Drug Monit. 1999 Apr;21(2):141-51
references: 10217331
references: J Am Coll Cardiol. 1997 Jan;29(1):187-93
references: 8996313
references: Int J Clin Pharmacol Ther. 2010 May;48(5):309-18
references: 20420787
references: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1692-7
references: 9990086
references: Int J Clin Pharmacol Ther. 1997 Jul;35(7):287-95
references: 9247842
references: N Engl J Med. 2004 Mar 4;350(10):1013-22
references: 14999113
references: J Urol. 2009 Mar;181(3):1444-51
references: 19157444
references: J Pharmacol Exp Ther. 2004 Mar;308(3):935-40
references: 14711935
references: Curr Urol Rep. 2005 Nov;6(6):405-9
references: 16238912
references: Eur Urol. 2005 Jul;48(1):102-9
references: 15936869
references: Clin Exp Hypertens. 2004 Oct-Nov;26(7-8):637-44
references: 15702618
references: Circulation. 2007 Jan 30;115(4):468-74
references: 17242274
references: Circ Res. 1971 Nov;29(5):437-45
references: 4330524
references: Eur J Clin Pharmacol. 2005 Sep;61(8):559-65
references: 16133553
references: J Clin Invest. 1998 Jan 15;101(2):471-8
references: 9435320
references: Br J Pharmacol. 2006 Feb;147 Suppl 2:S80-7
references: 16465186
references: J Pharmacol Sci. 2006;100(5):323-37
references: 16612046
references: Ann Clin Lab Sci. 1986 May-Jun;16(3):198-208
references: 2872849
references: Circulation. 2001 Apr 24;103(16):2072-7
references: 11319197
references: J Am Geriatr Soc. 2002 Jan;50(1):117-24
references: 12028256
references: Lancet. 1998 Feb 14;351(9101):478-84
references: 9482439
references: Adv Cardiol. 2006;43:1-16
references: 16936468
references: Recept Channels. 2003;9(4):279-90
references: 12893539
references: Pharmacol Res. 2001 Sep;44(3):161-82
references: 11529684
references: Naunyn Schmiedebergs Arch Pharmacol. 1997 Feb;355(2):239-49
references: 9050018
references: J Pharmacol Exp Ther. 2002 Apr;301(1):129-37
references: 11907166
references: Curr Hypertens Rep. 2010 Jun;12(3):162-9
references: 20431967
references: Circ Arrhythm Electrophysiol. 2008 Dec;1(5):321-3
references: 19808425
references: J Cardiovasc Pharmacol. 2006 Nov;48(5):199-206
references: 17110801
references: Clin Pharmacol Ther. 2007 Mar;81(3):377-85
references: 17339867
references: Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2446-52
references: 16415073
references: Pharmacol Rev. 1985 Mar;37(1):1-24
references: 2408285
references: Urology. 2003 Jan;61(1):37-49
references: 12559262
references: Angiology. 2000 Apr;51(4):295-300
references: 10778999
references: Eur J Pharmacol. 1998 Apr 10;346(2-3):227-36
references: 9652364
references: Prog Cardiovasc Dis. 2004 Jan-Feb;46(4):349-73
references: 14961457
references: Curr Med Chem. 2009;16(33):4481-9
references: 19835561
references: J Biol Chem. 1998 Nov 27;273(48):32158-66
references: 9822693
references: Clin Ther. 1997;19 Suppl A:39-52
references: 9385504
references: Ther Clin Risk Manag. 2005 Jun;1(2):157-67
references: 18360555
references: Eur J Clin Pharmacol. 1992;42(6):577-80
references: 1623896
references: Auton Neurosci. 2001 Jul 20;90(1-2):116-21
references: 11485277
references: Drug Saf. 2008;31(6):505-14
references: 18484784
references: Naunyn Schmiedebergs Arch Pharmacol. 2008 Feb;376(6):431-40
references: 18092154
references: Br J Clin Pharmacol. 2008 Dec;66(6):896-7
references: 18823303
references: BJU Int. 2007 Nov;100(5):1007-14
references: 17922785
references: Arzneimittelforschung. 1993 Apr;43(4):461-4
references: 8494577
references: Circulation. 2007 Jan 30;115(4):430-1
references: 17261670
references: Am J Physiol. 1986 Oct;251(4 Pt 2):H764-73
references: 3021001
references: Ann Noninvasive Electrocardiol. 2005 Jan;10(1):88-101
references: 15649244
references: Biol Psychol. 2007 Feb;74(2):224-42
references: 17182165
references: J Urol. 2004 Jun;171(6 Pt 1):2311-5, quiz 2435
references: 15126811
references: J Cardiovasc Pharmacol. 2000 Feb;35(2):334-40
references: 10672870
references: Br J Clin Pharmacol. 1996 Jan;41(1):73-5
references: 8824696